In this episode of The Wellness Files, host Kari Beal sits down with obesity medicine specialist Dr. Christopher McGowan to discuss Retatrutide, the highly anticipated "triple agonist" weight loss drug currently in Phase 3 trials. They dive into its unprecedented weight loss potential, unique side effects like skin sensitivity, and the dangerous black market pathways patients are using to access it before FDA approval. 

00:00 – Intro: The massive hype surrounding Retatrutide ("RETA")
01:58 – The dangers of seeking unapproved research drugs online
02:47 – Weight loss data: Reta's gastric bypass-level results vs. Wegovy https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
04:22 – How the "triple G" agonist works on three gut hormones
07:04 – The reality of muscle loss and preserving lean mass
08:41 – Side effects: Elevated heart rate and painful skin sensitivity
11:13 – Thyroid cancer warnings, pancreatitis, and contraindications
13:10 – Long-term safety: GLP-1 history vs. the new glucagon pathway
14:59 – Additional health benefits: Reversing fatty liver and joint pain
16:25 – The TikTok "Ratatouille" trend and black market peptide risks
19:47 – Projected FDA approval timeline and safe, legal alternatives

Science communicator Morgan McSweeney, PhD (known online as "Dr. Noc"), joins the podcast to explain how emerging mRNA flu vaccines differ from traditional egg-grown shots and details the latest clinical trial data on their efficacy and side effects. We broaden the conversation on mRNA vaccines, provide critical context on rare risks like myocarditis (heart inflammation), and outline how safety is actively monitored. 
00:00 – Explaining mRNA vaccine technology versus traditional egg-grown flu shots.
02:12 – Addressing common genetic misconceptions and how mRNA is cleared from the body.
04:40 – Highlighting Phase III clinical trial data, vaccine efficacy, and side effects.
08:10 – Selecting the right flu vaccine based on age, health history, and doctor consultation.
09:55 – Clarifying clinical trial cardiac safety data and mRNA heart inflammation risks.
11:49 – Putting rare side effects in context with the severe health risks of contracting the flu.
14:22 – Highlighting regional flu risks in South Carolina and protecting vulnerable communities.
16:09 – Actionable advice for natural immune support, including sleep, diet, and exercise.
18:09 – Detailing how federal agencies monitor vaccines for rare safety signals.
20:54 – Navigating vaccine hesitancy and improving patient-doctor communication.

Gastroenterologist Dr. Veeral Oza explains why pancreatic cancer is so hard to catch early and how a new oral KRAS-targeting drug, known as daraxonrasib, is showing promising survival gains for some patients. He also shares a key early red flag doctors don’t want you to ignore: new-onset diabetes after age 50 (or sudden worsening control)

00:00 intro
00:03 Why pancreatic cancer is often caught late; what “earlier detection” could look like.
00:04 Stats + why this disease is so lethal; spotlight on the new drug.
00:05 Cancer biology basics; KRAS and how tumors “hide” from the immune system.
00:06 How Daraxonrasib works (switch/clamp concept) + survival improvement discussion.
00:08 Why cancers adapt; why personalized medicine may be the future.
00:09 Immunotherapy and “cancer vaccine” concept explained.
00:11 Side effects + why an oral pill with minimal hair loss matters.
00:13 How doctors handle biopsy timing, referrals, and the diagnosis conversation.
00:17 “Breakthrough therapy”/expanded access: what it means for availability.
00:18 What’s next: AI + earlier diagnosis research; diabetes as a major warning sign.
00:20 Symptoms of diabetes; when to ask “could this be pancreatic?”
00:22 Blood-test screening research + survival trends improving over time.
00:24 Other possible symptoms: weight loss, jaundice, fatigue; anatomy explains why.
00:28 Wrap-up + key takeaway: don’t ignore unexplained weight loss or glucose changes. 

Functional medicine doctor Katherine Birchenough and nutrition coach Sarah Wilson explain the “internal sunscreen” trend, how plant pigments and certain nutrients may build up in skin and help reduce UV-related damage. They stress it’s an extra layer of defense (not a replacement for topical sunscreen) and share practical food picks, supplement options, and common sun-safety myths.

00:00 – intro
00:01 – Why summer produce matters; pigments from plants can accumulate in skin and help reflect UV rays.
00:02 – Guests’ backgrounds; nutrition as one “layer” of sun protection.
00:03 – Lycopene spotlight: tomatoes/tomato paste; studies suggest less UV redness after weeks of intake; cooked + olive oil may help absorption.
00:04 – Other lycopene foods (watermelon, red/pink produce); broader pigments: blues/purples (anthocyanins), yellow/orange (flavonoids).
00:06 – Layered protection: mineral sunscreen, clothing, hats/scalp protection.
00:08 – Supplements: lycopene; Polypodium leucotomos (fern extract/Heliocare); repair support like nicotinamide (B3).
00:10 – Omega-3s for cell membranes; astaxanthin (seafood) for antioxidant support + “glow.”
00:13 – Vitamins C & E for collagen/antioxidant repair.
00:14 – Myth-busting: tans aren’t enough; clouds still burn; darker skin can burn; timing + daily face/hand SPF; driving-side sun damage.
00:16 – Takeaways: eat the rainbow—brighter/darker pigments = better.

Defense Secretary Pete Hegseth announced a new testosterone-deficiency screening program for service members, but endocrinologist and former military doctor Dr. Karl Nadolsky says the science doesn’t support universal testing in people without symptoms. In this episode, we break down who should be evaluated, why obesity/sleep apnea and certain injuries or medications can lower testosterone, and what risks come with unnecessary testosterone replacement therapy (including infertility).

00:00 intro
00:01:00 Meet Dr. Karl Nadolsky (endocrinologist, former military physician)
00:02:02 Full clip: Pete Hegseth explains annual testing for 30+; optional under 30
00:04:31 What testosterone does/doesn’t do for performance; who truly benefits from TRT
00:05:30 How common is “true” hypogonadism vs functional low T (obesity/sleep apnea/diabetes)
00:06:48 Why widespread screening isn’t recommended; lack of evidence for better outcomes
00:08:44 Medication/injury causes: opioids, TBI, blast/testicular trauma; why targeted screening fits
00:11:59 Main risks: false positives, wrong timing/conditions for labs, unnecessary anxiety/cost
00:13:38 Proper workup: treat root causes first; don’t miss pituitary disease or sleep apnea
00:14:06 TRT tradeoffs: fertility suppression, potential long-term dependence; steroid/male-clinic pitfalls
00:16:16 Women and testosterone: testing mostly for high levels; limited menopause libido use
00:19:29 Military endocrinology + why expert input/task force matters for policy
00:22:15 Practical alternative: checkbox-based risk triggers and symptom screening at annual physicals
00:23:34 Closing: keep politics out; follow data and build evidence-based protocols

Host Kari Beal interviews Dr. George Ibrahim about the surge in peptide use for injury recovery, energy, weight loss, and more, plus why many peptides aren’t FDA-approved and have limited human data. They break down common peptides (BPC-157, TB-500, CJC-1295/ipamorelin), discuss safety and cancer/angiogenesis concerns, and explain why buying “research peptides” online can be risky.

00:00 intro
00:01 BPC-157 & TB-500 explained (repair/cleanup crews); angiogenesis + cancer concern setup.
00:03 What a peptide is; how structure drives function (key/receptor).
00:05 Evidence overview (animal vs limited human); why combine BPC-157 + TB-500.
00:07 Safety in practice: “peptide flush” and minor reactions.
00:08 Cancer-risk discussion; screening for cancer history.
00:10 Quality control: pharmacy “human-use” vs online “research” peptides; contamination/dosing risks.
00:12 How to tell: if you can buy it yourself online, it’s not human-use.
00:14 “Best” peptide pick: CJC-1295 + ipamorelin; growth-hormone support + realistic timeline.
00:17 Cost estimates; prioritizing hormones, then GH support.
00:18 Why few human trials (patents/funding).
00:20 FDA/compounding outlook; regulation and safety hopes.
00:22 Social media hype; questions to ask a doctor; special cautions (GLP-1s, tanning peptides).
00:24 More peptide uses (GHK-Cu for brain + hair/skin/nails); closing + correction (“endotoxins”).

A new FDA-approved treatment for Hunter syndrome (MPS II) is giving families hope, but it’s not a cure. We explore how close researchers may be to a cure, including promising gene therapy clinical trials, and what experts say still needs long-term study.

00:00 intro
00:45 How this story began: a mom reaches out about newly approved Avlayah.
01:03 Why it matters: therapy designed to cross the blood-brain barrier.
01:20 The emotional center: two moms bond while navigating the same diagnosis.
02:23 Hunter syndrome (MPS II) explained: missing enzyme, sugar buildup, organ/brain damage.
03:40 How the “next-gen” enzyme replacement works using an enzyme transport vehicle.
04:16 Early impact: reported behavioral/physical improvements and infusion-center support.
05:36 “Not a cure” → what a cure could look like; intro to gene therapy.
06:23 London trial spotlight: one-time ex vivo gene therapy; early (anecdotal) improvements. https://www.gosh.nhs.uk/news/gosh-manufactures-new-gene-therapy-for-rare-condition/
08:01 U.S. clinical trial in New Jersey: timelines and what’s still unknown. https://clinicaltrials.gov/study/NCT07236606
08:48 Physician Assistant Laura Buch: long-term durability, dosing questions, and rare-disease trial limits.
10:03 Advocacy + how to find trials on ClinicalTrials.gov; closing thoughts.
https://clinicaltrials.gov/study/NCT03566043

The federal government is fast-tracking some psychedelic-based medicines for research and development. Emergency physician Dr. Jonathan Leak explains how these therapies may work in the brain and if they’re safe.

00:00 — Fire captain recounts suicidal crisis; psilocybin changes his outlook and family life
00:36 — Intro: what psychedelics might do (neurotransmitters/neuroplasticity) and the safety question
00:54 — Why now: executive order to speed development; focus on treatment-resistant depression, PTSD, addiction
01:23 — Arizona psilocybin trial for first responders; content warning for sensitive topics
02:05 — Mark Herman’s story: chronic trauma, “fight or flight,” and seeking relief
03:01 — Research barriers from past criminalization; trial details and demand/waitlist
04:22 — Career risks/stigma for officers; underground use; dosing and safety concerns
05:01 — Black market concerns; funding push; hopes for right-to-try and guardrails as access expands
07:20 — Interview begins: Dr. Leak’s credentials; ketamine currently used in psychedelic therapy
08:15 — What drugs are discussed: psilocybin, ibogaine, methylone/MDMA
09:00 — Evidence/history; why these may help PTSD, depression, addiction
10:53 — How they may work: receptors + neuroplasticity + psychedelic experience; importance of therapy integration
12:36 — Brain connectivity shifts; new pathways; how psilocybin is dosed and how long sessions last
15:01 — Patents/formulations; molecule tweaks vs process patents
16:02 — MDMA/methylone differences; trauma processing and study outcomes; need for certified care
18:08 — Clinic model questions; side effects, monitoring, and scaling sessions safely

Musician Carnie Wilson is raising awareness about tardive dyskinesia (TD), an uncontrolled movement disorder that often goes undiagnosed. She shares why she’s advocating for screening, how stigma can keep people silent, and where listeners can find support and resources. 

00:00 – intro
00:01:05 – What TD is: common symptoms (face/lips, chewing-like movements, eye twitch).
00:01:29 – Main cause: dopamine receptor–blocking meds (often antipsychotics); risk factors + generations of meds.
00:02:21 – Why TD is missed: many cases undiagnosed; importance of recognizing symptoms.
00:02:42 – Carnie on speaking up, getting screened, and how diagnosis can change lives.
00:04:53 – “Connecting with Carnie” campaign + where to find resources (connectingwithcarney.com).
00:05:24 – Bell’s palsy story as a way to relate to visible conditions and shame/stares.
00:07:10 – What helps diagnosis: noticing changes, telling your healthcare provider, rejecting shame.
00:09:33 – How TD impacts daily life (driving, sleep, leaving home) + real patient stories.
00:10:17 – Carnie on depression/addiction, stigma, and checking in on mental health.
00:14:23 – Medication/research question; Carnie points listeners back to medical resources.
00:16:18 – Why this cause matters to her: family experience with mental illness + compassion.
00:19:10 – Specific symptoms to watch for + encouragement to seek help.
00:20:30 – Final call to visit the campaign site; thanks and outro. 

USC School of Medicine Greenville experts break down lifestyle medicine and the evidence behind its “six pillars.” They discuss how food, exercise, sleep, stress management, social connection, and avoiding risky substances can improve chronic disease outcomes—and even support brain health in depression, Alzheimer’s risk, and more.

00:00 Intro
00:47 Welcome + live event at USC School of Medicine Greenville
02:10 Guest intros: Dean/primary care, neuroscientist, lifestyle program director
03:00 Why lifestyle medicine matters in med school + patient care
07:27 Real-life examples: hypertension, sodium, “food as medicine” (beets/flax)
09:13 Exercise & depression: blood flow, muscle-brain signaling, BDNF
12:35 Brain health + dementia risk: six pillars may slow cognitive decline
14:05 Parkinson’s study: tandem cycling benefits patients + caregivers
14:49 Curriculum: 109+ hours integrated across 4 years
15:51 Gut-brain connection: microbiome, fiber, ultra-processed foods
19:03 Social connection: loneliness, group care, “social capital”
22:21 Lifestyle vs functional medicine; the six pillars defined
23:40 Supplements + misinformation; magnesium; third-party testing (USP)
26:02 How to vet health info online (“too good to be true”)
29:02 Audience Q&A: antidepressants timeline; exercise outdoors
31:06 Motivation strategies: small goals, remove barriers, prioritize sleep
32:27 Organic vs frozen produce: cost-effective options + washing
35:07 Exercise guidelines by age + strength training + bone health
38:05 Cooking skills: culinary medicine + mobile teaching kitchen